Sign In
News Digest /
Ticker: NVS
Ticker: NVS
03:53am, Friday, Mar 27, 2026
Novartis is planning to acquire U.S. biotech firm Excellergy for up to $2 billion, boosting its immunology portfolio with a focus on food allergy treatments. The deal complements recent acquisitions, marking a robust biotech expansion strategy.
04:44am, Tuesday, Oct 28, 2025
Novartis CEO Vas Narasimhan insists major acquisitions remain on the table, spotlighting the $12B Avidity deal amid a strong cash flow and steady sales growth despite generic pressure.
09:09am, Thursday, Jun 26, 2025
Incyte (NASDAQ: INCY) shares rose 3.6% following Bill Meury's appointment as CEO, succeeding Hervé Hoppenot. With 30 years of industry experience, Meury aims to enhance R&D and growth. Traders should monitor Incyte for potential advancements in its product lineup.
06:52am, Friday, Jun 13, 2025
Novo Nordisk (COPENHAGEN: NOVO) has reclaimed its status as Europe's largest company, following a leadership change. Traders should monitor its innovative biopharmaceutical strategy and market expansion for insights on potential stock performance and growth opportunities.
10:07am, Monday, May 12, 2025
Swiss pharma giant Novartis (SIX: NOVN) vows to continue producing malaria and leprosy medications amid potential aid cuts. With plans to invest $490M in R&D by 2025, the company aims to bolster global health, creating new investment opportunities for traders.
03:22am, Wednesday, Apr 23, 2025
Novartis and Sanofi CEOs advocate for higher drug prices in the EU to combat financial strains from tariffs and regulations. This move could boost profits but risks public backlash. Traders should monitor impacts on shares and market dynamics closely.
06:37am, Tuesday, Apr 22, 2025
Key earnings announcements from April 22-25 include Tesla, SAP, Novartis, Philip Morris, IBM, Google (Class C & A), Procter & Gamble, T-Mobile, and AbbVie. Investors should watch for EPS results and market reactions as Q1 2025 wraps up.
03:44am, Monday, Feb 24, 2025
Amgen (NASDAQ: AMGN) invests $200 million in a new tech center in Hyderabad, India, focusing on AI and data science for drug development. This move enhances its market presence and aligns with U.S.-India trade talks. Traders should monitor its growth potential.
06:14am, Thursday, Nov 21, 2024
Novartis (SIX: NVS) boosts its sales growth forecast from 5% to 6% CAGR (2023-2028), surpassing market expectations. Analysts see potential bullish sentiment, despite challenges like patent expirations and competition from biosimilars. Stay informed!
08:44am, Tuesday, Oct 29, 2024
**Upcoming Earnings Report Alert: October 29, 2024**
Major companies announcing earnings today include Visa, AMD, Stryker, McDonald's, Novartis, Pfizer, and HSBC. Watch for insights into consumer trends, healthcare growth, and market uncertainties! Stay tuned for detailed analysis.
08:30am, Friday, Jul 26, 2024
Thorough guide to selecting dividend stocks: focus on sector selection, financial ratios, management quality, risk assessment, and portfolio diversification to balance income and growth opportunities.
